First Citizens BancShares (FCNCA) Earnings Analysis

First Citizens BancShares (FCNCA) next reports earnings on 2026-10-22, consensus EPS 45.62 USD. Last quarter (2026-07-23) it beat with EPS 0.5709 USD vs 0.4069 USD est (+40.3%). It has beaten estimates in 6/8 recent quarters (75%). Trailing P/E 11.95.

Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades

When does FCNCA next report earnings?

Next earnings date2026-10-22
Consensus EPS estimate45.62 USD
Revenue estimate2.23B

FCNCA earnings history — beats and misses

Quarter (report date)EPS actualEPS est.SurpriseResult
2026-07-230.5709 USD0.4069 USD+40.3%Beat
2026-04-2344.86 USD39.56 USD+13.4%Beat
2026-01-230.5127 USD0.4399 USD+16.5%Beat
2025-10-2344.62 USD41.87 USD+6.6%Beat
2025-07-2544.78 USD39.71 USD+12.8%Beat
2025-04-2437.79 USD37.91 USD-0.3%Miss
2025-01-2445.1 USD39.32 USD+14.7%Beat
2024-10-2445.87 USD47.4 USD-3.2%Miss

Beat rate: 6/8 (75%) over reported quarters with consensus data.

FCNCA valuation and analyst view

Trailing P/E11.95
Trailing EPS189.27 USD
Price / book1.12
Dividend yield0.40%
Market cap23.82B
Analyst consensusHold (2 buy / 9 hold / 0 sell)
Avg price target2,246.67 USD

Related research pages

Frequently asked questions

When is First Citizens BancShares (FCNCA)'s next earnings date?

First Citizens BancShares is next scheduled to report on 2026-10-22, with a consensus EPS estimate of 45.62 USD and revenue estimate of 2.23B.

Did FCNCA beat earnings last quarter?

In its 2026-07-23 report, FCNCA posted EPS of 0.5709000000000001 USD versus a 0.4069 USD estimate — a beat of 40.3%.

What is FCNCA's earnings track record?

Over the last 8 reported quarters with consensus data, FCNCA beat estimates 6 times (75%).

What is FCNCA's current P/E ratio and EPS?

FCNCA trades at a trailing P/E of 11.95 on trailing EPS of 189.2678504027581 USD.

What do analysts rate FCNCA?

Analyst consensus is "Hold" across 11 ratings (0 strong buy, 2 buy, 9 hold, 0 sell, 0 strong sell). Average 12-month price target: 2246.67 USD.